Online citations, reference lists, and bibliographies.
← Back to Search

Evaluation Of Polyalkylcyanoacrylate Nanoparticles As A Potential Drug Carrier: Preparation, Morphological Characterization And Loading Capacity.

G. Puglisi, G. Giammona, M. Fresta, B. Carlisi, N. Micali, A. Villari
Published 1993 · Materials Science, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Some physicochemical behaviours were investigated of polyethyl- (PECA) and polyisobutylcyanoacrylate (PICA), which, in recent years, have been proposed as nanoparticle colloidal systems for drug carrying. We observed the influence of preparation conditions, such as pH value and surfactant concentration, on parameters such as particle size and polymer molecular weight. Lower operating pH values (0-2) resulted in smaller nanoparticles than those prepared at pH 5.5. The polymer molecular weight was also a function of pH: low molecular weight at low pH and vice-versa. The surfactant concentration positively influenced main particle size and polymer molecular weight. These trends were independent of type of monomer; in fact, both ethyl- (ECA) and isobutyl-2-cyanoacrylate (ICA) showed the same behaviour. Loading capacity, as well as release profile, of the two polymers were evaluated using fluorescein as a model drug. Whereas both polymers showed almost the same release profile, there was a difference in the amount of encapsulated probe: higher aliquots for PICA than for PECA. Storage effects on such physicochemical parameters were also tested.
This paper references
[An original procedure for preparing nanocapsules of polyalkylcyanoacrylates for interfacial polymerization].
N. al Khouri (1986)
10.1016/0378-5173(86)90053-0
Enhancement of the myotic response of rabbits with pilocarpine-loaded polybutylcyanoacrylate nanoparticles
T. Harmia (1986)
10.1016/0378-5173(83)90133-3
Polybutylcyanoacrylate nanoparticles for the delivery of [75Se]norcholestenol
J. Kreuter (1983)
10.1146/ANNUREV.ME.39.020188.001253
Transdermal delivery of drugs.
L. Brown (1988)
Current innovations in drug delivery.
D. Ganderton (1987)
New routes of administration and new delivery systems of anesthetics.
T. Stanley (1988)
10.1002/MACP.1979.021800119
Inverse problems in polymer characterization: Direct analysis of polydispersity with photon correlation spectroscopy
S. Provencher (1979)
10.1002/JPS.2600710717
Toxicity of polyalkylcyanoacrylate nanoparticles II: Doxorubicin-loaded nanoparticles.
P. Couvreur (1982)
10.1111/j.2042-7158.1979.tb13510.x
Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties
P. Couvreur (1979)
10.1002/JPS.2600651217
Polymerized micelles and their use as adjuvants in immunology.
G. Birrenbach (1976)
10.1016/0378-5173(86)90236-X
Development of a new process for the manufacture of polyisobutylcyanoacrylate nanocapsules
N. A. K. Fallouh (1986)
10.1002/JPS.2600651115
In vitro studies of poly(methyl methacrylate) adjuvants.
J. Kreuter (1976)
10.1002/MACP.1989.021900713
Water effects on the zwitterionic polymerization of cyanoacrylates
I. C. Eromosele (1989)
10.1016/0378-5173(83)90166-7
Pharmacokinetics and Distribution of a Biodegradable Drug-carrier
L. Grislain (1983)
10.1016/0378-5173(83)90084-4
Molecular weights of polycyanoacrylate nanoparticles
M. A. Elegakey (1983)
10.1038/clpt.1987.146
Variable glyceryl dinitrate formation as a function of route of nitroglycerin administration
P. Noonan (1987)
10.1016/0168-3659(91)90058-L
Polyalkylcyanoacrylate nanoparticles as drug carrier: present state and perspectives
P. Couvreur (1991)
10.1016/0010-4655(82)90173-4
A constrained regularization method for inverting data represented by linear algebraic or integral equations
S. Provencher (1982)
10.1016/0378-5173(86)90021-9
Biodistribution of poly(butyl 2-cyanoacrylate) nanoparticles in rabbits
S. J. Douglas (1986)



This paper is referenced by
10.1080/02652040010018146
Preparation and in vivo evaluation of parenteral metoclopramide-loaded poly(alkylcyanoacrylate) nanospheres in rats
M. A. Radwan (2001)
10.1016/S0378-5173(99)00311-7
Response surface methodology as a predictive tool for determining the effects of preparation conditions on the physicochemical properties of poly(isobutylcyanoacrylate) nanoparticles.
P. McCarron (1999)
10.3109/1061186X.2012.712130
Nanoparticles-mediated drug delivery approaches for cancer targeting: a review
S. Sultana (2013)
An investigation into the feasibility of incorporating didanosine into innovative solid lipid nanocarriers
K. W. Kasongo (2010)
10.3109/02652049409034991
An interpretative analysis of the effect of the surfactants used for the preparation of polyalkylcyanoacrylate nanoparticles on the release process.
M. A. Vandelli (1994)
10.1002/1520-6017(200103)90:3<288::AID-JPS4>3.0.CO;2-5
Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir.
M. Fresta (2001)
10.1016/0378-5173(95)00142-6
Influence of the preparation conditions on poly(ethylcyanoacrylate) nanocapsule formation
G. Puglisi (1995)
10.1016/j.ijpharm.2009.04.045
Optimization of epirubicin nanoparticles using experimental design for enhanced intravesical drug delivery.
Li-Ching Chang (2009)
10.1002/JPS.2600840721
Pefloxacine mesilate- and ofloxacin-loaded polyethylcyanoacrylate nanoparticles: characterization of the colloidal drug carrier formulation.
M. Fresta (1995)
10.1016/j.ejmech.2011.04.003
Effects of external phase on D-cycloserine loaded W/O nanocapsules prepared by the interfacial polymerization method.
T. Musumeci (2011)
10.1016/0378-5173(94)90399-9
Entrapment of β-lactams antibiotics in polyethylcyanoacrylate nanoparticles: Studies on the possible in vivo application of this colloidal delivery system
G. Cavallaro (1994)
10.1016/0142-9612(96)81411-6
Preparation and characterization of polyethyl-2-cyanoacrylate nanocapsules containing antiepileptic drugs.
M. Fresta (1996)
10.3109/03639049409050235
Association of netilmicin Sulphate to poly(Alkylcyanoacrylate) Nanoparticles: Factors Influencing particle delivery Behaviour
M. Fresta (1994)
Semantic Scholar Logo Some data provided by SemanticScholar